M.C. Dobelbower

3.4k total citations
12 papers, 182 citations indexed

About

M.C. Dobelbower is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, M.C. Dobelbower has authored 12 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in M.C. Dobelbower's work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Urinary and Genital Oncology Studies (3 papers). M.C. Dobelbower is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Urinary and Genital Oncology Studies (3 papers). M.C. Dobelbower collaborates with scholars based in United States, Canada and Vietnam. M.C. Dobelbower's co-authors include Mitchell Machtay, Vivek S. Kavadi, Jian‐Yue Jin, Feng‐Ming Kong, Samir Narayan, Rebecca Paulus, Susannah G. Ellsworth, Puneeth Iyengar, Jeffrey D. Bradley and Christopher D. Koprowski and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

M.C. Dobelbower

11 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.C. Dobelbower United States 6 92 81 52 50 28 12 182
B. Noris Chiorda Italy 5 55 0.6× 150 1.9× 45 0.9× 38 0.8× 86 3.1× 18 218
Yuta Sekino Japan 7 52 0.6× 78 1.0× 54 1.0× 15 0.3× 12 0.4× 35 162
Karin Söderkvist Sweden 9 65 0.7× 114 1.4× 106 2.0× 84 1.7× 58 2.1× 32 279
M. Deberne France 7 114 1.2× 45 0.6× 96 1.8× 21 0.4× 25 0.9× 14 162
Alfred Witjes Netherlands 8 38 0.4× 90 1.1× 133 2.6× 31 0.6× 10 0.4× 23 232
Manon Kissel France 10 62 0.7× 82 1.0× 93 1.8× 41 0.8× 57 2.0× 33 265
Brian K. Chang United States 4 39 0.4× 105 1.3× 69 1.3× 62 1.2× 114 4.1× 4 200
Chinnamani Eswar United Kingdom 7 26 0.3× 104 1.3× 25 0.5× 61 1.2× 72 2.6× 16 177
H. Wengenmair Germany 9 47 0.5× 260 3.2× 105 2.0× 67 1.3× 35 1.3× 21 333
Dagmar Klotz Norway 10 84 0.9× 251 3.1× 52 1.0× 75 1.5× 12 0.4× 14 302

Countries citing papers authored by M.C. Dobelbower

Since Specialization
Citations

This map shows the geographic impact of M.C. Dobelbower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Dobelbower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Dobelbower more than expected).

Fields of papers citing papers by M.C. Dobelbower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Dobelbower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Dobelbower. The network helps show where M.C. Dobelbower may publish in the future.

Co-authorship network of co-authors of M.C. Dobelbower

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Dobelbower. A scholar is included among the top collaborators of M.C. Dobelbower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Dobelbower. M.C. Dobelbower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chun, Stephen G., Chen Hu, Ritsuko Komaki, et al.. (2024). Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer. JAMA Oncology. 10(8). 1111–1111. 10 indexed citations
2.
3.
Kole, Adam J., Hitesh Batra, Drexell H. Boggs, et al.. (2021). Predictors of In-Hospital Death in Patients with Lung Cancer Admitted for Acute Radiation Pneumonitis: A Healthcare Cost and Utilization Project (HCUP) Analysis. Clinical Lung Cancer. 22(5). e716–e722. 8 indexed citations
4.
Schneider, Craig S., Robert A. Oster, Aparna Hegde, et al.. (2021). Nonoperative Treatment of Large (5–7 cm), Node-Negative Non–Small Cell Lung Cancer Commonly Deviates From NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 20(4). 371–377.e6. 6 indexed citations
5.
Bogart, Jeffrey A., Gregory A. Masters, Huijuan Zhu, et al.. (2019). Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on the experimental thoracic radiotherapy (TRT) arms of CALGB 30610 (Alliance) / RTOG 0538. Annals of Oncology. 30. v711–v711. 3 indexed citations
6.
Hu, Chen, Weili Wang, Joseph O. Deasy, et al.. (2017). Effect of PTV and Collimator Margins on Tumor Control for Patients with Stage III Non-small Cell Lung Cancer in NRG Oncology RTOG-0617. International Journal of Radiation Oncology*Biology*Physics. 99(2). S181–S182. 1 indexed citations
7.
Jin, Jian‐Yue, Chang‐Ping Hu, Yufen Xiao, et al.. (2017). Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617). International Journal of Radiation Oncology*Biology*Physics. 99(2). S151–S152. 46 indexed citations
8.
Митин, Тимур, Anthony L. Zietman, Niall M. Heney, et al.. (2015). Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233. International Journal of Radiation Oncology*Biology*Physics. 94(1). 67–74. 35 indexed citations
9.
10.
Митин, Тимур, Anthony L. Zietman, Donald S. Kaufman, et al.. (2014). Long-term outcomes among patients who achieve complete or near-complete responses after the induction phase of bladder-preserving combined modality therapy for muscle-invasive bladder cancer: A pooled analysis of RTOG 9906 and 0233.. Journal of Clinical Oncology. 32(4_suppl). 284–284. 2 indexed citations
11.
Dobelbower, M.C., Sharon A. Spencer, Richard A. Popple, et al.. (2012). Stereotactic Body Radiation Therapy (SBRT) for Lung Malignancies: Preliminary Toxicity Results Using a Flattening Filter-free Linear Accelerator Operating at 2400 Monitor Units per Minute. International Journal of Radiation Oncology*Biology*Physics. 84(3). S557–S558. 3 indexed citations
12.
Fiveash, John B., Jun Duan, James M. Markert, et al.. (2010). A Phase II Isotoxicity Study of Spinal Radiosurgery/SBRT. International Journal of Radiation Oncology*Biology*Physics. 78(3). S278–S278. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Noris Chiorda Breakdown of academic impact, for papers by Yuta Sekino Breakdown of academic impact, for papers by Karin Söderkvist Breakdown of academic impact, for papers by M. Deberne Breakdown of academic impact, for papers by Alfred Witjes Breakdown of academic impact, for papers by Manon Kissel Breakdown of academic impact, for papers by Brian K. Chang Breakdown of academic impact, for papers by Chinnamani Eswar Breakdown of academic impact, for papers by H. Wengenmair Breakdown of academic impact, for papers by Dagmar Klotz
Rankless by CCL
2026